Agree. Guidance is key to any sustained move up post ER. Prelkminaty, Q4 resulted have already been announced. I think that EKSO could be silent on pilots maturing and new deals as part of the Chinese JV partnership. Until they purchase the second truanch, EKSO may not be able to overtly influence share price. If this is correct, then outside the ER, we shouldn’t see another PR until after March.
News 
Market Data 
Discover 
